250
Participants
Start Date
October 1, 2012
Primary Completion Date
July 3, 2014
Study Completion Date
April 4, 2016
Apremilast
Apremilast 30 mg tablet orally BID
Etanercept
Etanercept 50 mg evaluator/subject-blinded SC QW injection
Placebo tablet
Placebo tablets BID
Placebo injection
Once weekly evaluator/subject-blinded SC placebo (1 mL x 2 injections SC)
Riga 1st Hospital Skin and Sexually Transmitted Diseases Clinical Centre, Riga
Adoria Ltd, Riga
Family Doctor's Indra's Kenina's Practice, Riga
Cliniques Universitaires St-Luc, Brussels
University Hospital Carl Gustav Carus, Dresden
Arija's Ancane's Family Doctor Private Practice, Baldone
LTD M & M centrs, Ādaži
Sinclair Dermatology, East Melbourne
Health Center of Talsi Ltd, Talsi
University Hospital of Liege CHU Liege, Liège
Veracity Clinical Research, Woolloongabba
UniversitatsKlinikum Leipzig A.o.R., Leipzig
The Skin Centre, Benowa
Allergo-Derm Bakos Kft., Szolnok
Rheumatology unit Ward 5C Queen Elizabeth Hospital, Woodville
Gairdner Hospital, Victoria Park
Fremantle Dermatology, Fremantle
Tolna Megyei Balassa Janos Korhaz, Szekszárd
University Hospital Ghent, Ghent
NYU Department of Dermatology, New York
Psoriasis Study Center, Berlin
Dermatologische Praxis, Berlin
Forest Hills Dermatology Group, Forest Hills
Klinische Forschung Berlin - Buch GmbH, Berlin
University of Pittsburgh Medical Center, Pittsburgh
Gemeinschaftspraxis Mahlow, Mahlow
George Washington University, Washington D.C.
SCIderm GmbH, Hamburg
Lawrence Green, MD, LLC, Rockville
Virginia Clinical Research Inc, Norfolk
Comprehensive Center of Inflammatory Medicine (CCIM) University Medical Center Schleswig-Holstein, Lübeck
The Education and Research Foundation, Lynchburg
Wake Forest University Health Sciences, Winston-Salem
University of North Carolina, Chapel Hill
Duke University Medical Center, Durham
Atlanta Dermatology, Vein and Research Center, PC, Alpharetta
Florida Center for Dermatology, PA, Jacksonville
Florida Academic Dermatology Center, Miami
International Dermatology Research, Miami
Renstar Medical Research, Ocala
Tennesse Clinical Research Center, Nashville
Praxis fr Dermatologie und Venerologie, Wuppertal
Ohio State University Medical Center, Columbus
University Hospitals Case Medical Center, Cleveland
Dawes Fretzin Clinical Research Group, LLC, Indianapolis
University Hospital Munster, Münster
Dermatology Clinic of Tartu University Hospital, Tartu
Dermamedica, Náchod
NorthShore University HealthSystem, Skokie
University Hospital Frankfurt, Frankfurt
Southern Illinois University School of Medicine, Springfield
South Estonian Hospital Ltd, Meegomäe Village, Võru County
Universitatsklinikum Heidelberg, Heidelberg
Dermatology and Advanced Aesthetics, Lake Charles
Teckton Research, Austin
Horizons Clinical Research, Denver
Arizona Research Center, Phoenix
Hautklinik Universitatsklinikum Erlangen, Erlangen
University of California San Diego Medical Center, San Diego
University of California Irvine-Department of Dermatology, Irvine
Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield
Dermatology Associates of Seattle, Seattle
Dartmouth Hitchcock Medical Center, Lebanon
Robert Wood Johnson Medical School, Somerset
Eastern Canada Cutaneous Research Associates Ltd, Halifax
Skin Center for Dermatology, Peterborough
K. Papp Clinical Research Inc., Waterloo
Siena Medical Research, Montreal
Q & T Research Sherbrooke Inc., Sherbrooke
Dorothea, Kožní a korektivne dermatologické pracovište, Chomutov
Východoceské dermatologické centrum Homea s.r.o., Pardubice
Krajská nemocnice Pardubice, Kožní oddelení, Pardubice
Dermatovenerologicka ambulance, Svitavy
Koznia zilni ambulance, Ústí nad Labem
Institute for Health Services Research in Dermatology and Nursing - IVDP, University Medical Center, Hamburg
Academic Medical Center, Amsterdam
Radboud University Medical Centre, Nijmegen
University Hospital of Wales, Cardiff
Leeds Teaching Hospitals Trust, Leeds
Whipps Cross University Hospital, London
St Helier Hospital, London
George Eliot Hospital, Nuneaton
Lead Sponsor
Amgen
INDUSTRY